ArticleTransboundary and emerging diseases2021
Quantification of soya-based feed ingredient entry from ASFV-positive countries to the United States by ocean freight shipping and associated seaports.
Article in Transboundary and emerging diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Evaluating the effect of temperature on viral survival in plant-based feed during storage.Transboundary and emerging diseases · 2022Article
- Assessment of soy-based imports into the United States and associated foreign animal disease status.Transboundary and emerging diseases · 2022Article
- Quantification of soya-based feed ingredient entry from ASFV-positive countries to the United States by ocean freight shipping and associated seaports.Transboundary and emerging diseases · 2021Article
- Risk and Mitigation of African Swine Fever Virus in Feed.Animals : an open access journal from MDPI · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
African swine fever virus (ASFV) can survive in soya-based products for 30 days with T ½ ranging from 9.6 to 12.9 days in soya bean meals and soya oil cake. As the United States imports soya-based products from several ASFV-positive countries, knowledge of the type and quantity of these specific imports, and their ports of entry (POE), is necessary information to manage risk. Using the data from the International Trade Commission Harmonized Tariff Schedule website in conjunction with pivot tables, we analysed imports across air, land and sea POE of soya-based products from 43 ASFV-positive countries to the United States during 2018 and 2019. In 2018, 104,366 metric tons (MT) of soya-based products, specifically conventional and organic soya bean meal, soya beans, soya oil cake and soya oil were imported from these countries into the United States via seaports only. The two largest suppliers were China (52.7%, 55,034 MT) and the Ukraine (42.9%, 44,775 MT). In 2019, 73,331 MT entered the United States and 54.7% (40,143 MT) came from the Ukraine and 8.4% (6,182 MT) from China. Regarding POE, 80.9%-83.2% of soya-based imports from China entered the United States at the seaports of San Francisco, CA, and Seattle, WA, while 89.4%-100% entered from the Ukraine via the seaports of New Orleans, LA, and Charlotte, NC. Analysis of five-year trends (2015-2019) of the volume of soya imports from China indicated reduction over time (with a noticeably sharp decrease between 2018 and 2019), and seaport utilization was consistent. In contrast, volume remained high for Ukrainian soya imports, and seaport utilization was inconsistent. Overall, this exercise introduced a new approach to collect objective data on an important risk factor, providing researchers, government officials and industry stakeholders a means to objectively identify and quantify potential channels of foreign animal disease entry into the United States.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.